Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
R.R. Donnelley & Sons Company (RRD) (NYSE:RRD), a leading global provider of marketing and business communications, today introduces a comprehensive vaccination distribution toolkit — for healthcare providers, government agencies, retail pharmacies, and large enterprise organizations — aimed at delivering quick-turn marketing, communication, and operational support upon the release of an FDA-authorized COVID-19 vaccine.
With several COVID-19 vaccines under review for Emergency Use Authorization by the FDA, manufacturers, care providers, and associated companies will have an immediate need for vaccine distribution, related communication, and support materials.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Immediate production of a vaccine program involves many components, e.g., regulatory compliance, multiple vendor coordination, and speed-to-market challenges. RRD's vaccination distribution toolkit is designed to provide turnkey support in three key areas:
- Vaccine awareness – direct mail campaigns, digital communications, employee training materials, content and creative translations
- Clinician and retailer operational needs – signage and wayfinding, prep kits, temperature labels, POP displays, branded promotions and labels
- Post-vaccination support – care kits, proof of vaccination, second-dose reminders, tip sheets
The challenge of any large-scale, intra-pandemic vaccination effort is often compounded by the fact that many people are reluctant to get vaccinated. According to a recent survey by Sermo, more than 80% of physicians indicate that concerns regarding the safety of the COVID-19 vaccine could be the main barrier to adoption. Widespread vaccination will require extensive communications that thoughtfully incorporates messaging, imagery, reading level, and translation to resonate with a variety of populations.
"RRD's new vaccination distribution toolkit is rooted in the company's expertise in creating compelling communications distributed through direct mail, online channels, and physical locations," said Ken Gammon, Vice President, RRD Healthcare Solutions.
"Once a vaccine becomes available, its distribution will require swift, efficient mobilization of awareness campaigns and associated materials. This focused coordination of proven RRD solutions will not only empower businesses with a true sense of preparedness, but provide them access to the right tools to effectively and safely seize the moment."
About RRD
RRD is a leading global provider of multichannel business communications services and marketing solutions. With more than 35,000 employees across 29 countries, RRD offers the industry's most comprehensive offering of solutions designed to help companies—from Main Street to Wall Street—optimize customer engagement and streamline business operations across the complete customer journey. RRD offers a comprehensive portfolio of capabilities, experience and scale that enables organizations around the world to create, manage, deliver, and optimize their marketing and business communications strategies. For more information, visit the Company's web site at www.rrd.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201209005241/en/
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.